Evidence map›Paper›PMID 29761350›Full record

ArticleDrug delivery and translational research2018

Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.

Lara E Pereira, Tyana Singletary, Amy Martin, Chuong T Dinh, Frank Deyounks, Angela Holder, Janet McNicholl, Karen W Buckheit, Robert W Buckheit, Anthony Ham and 2 more

Open access · greenAbstract read
In one paragraph

Article in Drug delivery and translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Lara E PereiraLifeSource Biomedical LLC, Moffett Field, CA, USA.
Tyana SingletaryAnyar Inc, Fort Walton Beach, FL, USA.
Amy MartinCenters for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, GA, USA.
Chuong T DinhLibra Management Group, Decatur, Georgia.
Frank DeyounksLibra Management Group, Decatur, Georgia.
Angela HolderCenters for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, GA, USA.
Janet McNichollCenters for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, GA, USA.
Karen W BuckheitImQuest BioSciences, Frederick, MD, USA.
Robert W BuckheitImQuest BioSciences, Frederick, MD, USA.
Anthony HamImQuest BioSciences, Frederick, MD, USA.
David F KatzDepartment of Biomedical Engineering, Duke University, Durham, NC, USA.
James M SmithCenters for Disease Control and Prevention, Division of HIV/AIDS Prevention, Atlanta, GA, USA. ajo9@cdc.gov.
Centers for Disease Control and Prevention · USImQuest BioSciences (United States) · USAlibaba Group (United States) · USAnyar (United States) · USDuke University · US

Funding

Scientific CoreU19AI101961 · NIAID · IMQUEST BIOSCIENCES · PI KATZ, DAVID FRANK · 2012 to 2016
$14.3M
Intramural CDC HHS CC999999NIAID NIH HHS U19 AI101961NIH HHS Grant # 5U19AI101961
6 · The paper itself

Abstract

This study evaluated effects of differing gel volumes on pharmacokinetics (PK). IQB4012, a gel containing the non-nucleoside reverse transcriptase inhibitor IQP-0528 and tenofovir (TFV), was applied to the pigtailed macaque vagina and rectum. Vaginal gel volumes (1% loading of both drugs) were 0.5 or 1.5 ml; following wash-out, 1 or 4 ml of gel were then applied rectally. Blood, vaginal, and rectal fluids were collected at 0, 2, 4, and 24 h. Vaginal and rectal tissue biopsies were collected at 4 and 24 h. There were no statistically significant differences in concentrations for either drug between gel volumes within compartments at matched time points. After vaginal gel application, median IQP-0528 concentrations were ~ 10

Indexed as

Administration, RectalAnimalsAnti-HIV AgentsFemaleMacacaPyrimidinonesTenofovirVaginal Creams, Foams, and JelliesAnti-HIV AgentsIQP-0528PyrimidinonesTenofovirVaginal Creams, Foams, and JelliesHIV preventionIQP0528MacaquePharmacokineticsPrEPRectal gelVaginal gel

Identifiers

PMID29761350
PMCPMC6711467
OpenAlexW2801806477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.